[Clinical pharmacological aspects of a new hormone derivative (3-tetrahydropyranyl ether of 17-beta-estradiol)].
D000328:Adult; D004717:Endometrium / Q000187:drug effects; D004958:Estradiol / Q000627:therapeutic use*; D005260:Female; D006062:Gonadotropins / Q000652:urine; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D008875:Middle Aged; D010060:Ovulation / Q000187:drug effects; D011182:Postoperative Care; D011300:Preoperative Care; D011714:Pyrans / Q000627:therapeutic use*; D014596:Uterine Prolapse / Q000601:surgery*; D014621:Vagina / Q000187:drug effects; D014627:Vaginitis / Q000188:drug therapy*
D006062:Gonadotropins; D011714:Pyrans; D004958:Estradiol
Aspetti di farmacologia clinica di un nuovo derivato ormonale (3-tetraidropiraniletere del 17- -estradiolo.